Mesenchymal stem cell therapy for intractable neonatal disorders
Mesenchymal stem cell (MSC) transplantation has emerged as a new promising therapeutic strategy for the treatment of intractable and devastating neonatal disorders with complex multifactorial etiologies, including bronchopulmonary dysplasia (BPD), intraventricular hemorrhage (IVH), and hypoxic-ische...
Saved in:
Main Authors: | So Yoon Ahn (Author), Won Soon Park (Author), Se In Sung (Author), Yun Sil Chang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mesenchymal stem cells transplantation for neuroprotection in preterm infants with severe intraventricular hemorrhage
by: So Yoon Ahn, et al.
Published: (2014) -
Neonatal Diabetes Mellitus Due to KCNJ11 (KIR6.2) Mutation Successfully Treated with Sulfonylurea
by: Sehun Jang, et al.
Published: (2021) -
Initial and delayed thyroid-stimulating hormone elevation in extremely low-birth-weight infants
by: Shin Ae Yoon, et al.
Published: (2019) -
Corrigendum: Tolerability and Effect of Early High-Dose Amino Acid Administration in Extremely Low Birth Weight Infants
by: Jin Wha Choi, et al.
Published: (2020) -
Conservative Non-intervention Approach for Hemodynamically Significant Patent Ductus Arteriosus in Extremely Preterm Infants
by: Se In Sung, et al.
Published: (2020)